Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
07 2019
Historique:
received: 21 02 2019
accepted: 10 06 2019
revised: 23 07 2019
pubmed: 12 7 2019
medline: 3 1 2020
entrez: 12 7 2019
Statut: epublish

Résumé

The pathogenesis of Plasmodium falciparum malaria is linked to the variant surface antigen PfEMP1, which mediates tethering of infected erythrocytes to the host endothelium and is encoded by approximately 60 var genes per parasite genome. Repeated episodes of malaria infection result in the gradual acquisition of protective antibodies against PfEMP1 variants. The antibody repertoire is believed to provide a selective pressure driving the clonal expansion of parasites expressing unrecognized PfEMP1 variants, however, due to the lack of experimental in vivo models there is only limited experimental evidence in support of this concept. To get insight into the impact of naturally acquired immunity on the expressed var gene repertoire early during infection we performed controlled human malaria infections of 20 adult African volunteers with life-long malaria exposure using aseptic, purified, cryopreserved P. falciparum sporozoites (Sanaria PfSPZ Challenge) and correlated serological data with var gene expression patterns from ex vivo parasites. Among the 10 African volunteers who developed patent infections, individuals with low antibody levels showed a steep rise in parasitemia accompanied by broad activation of multiple, predominantly subtelomeric var genes, similar to what we previously observed in naïve volunteers. In contrast, individuals with intermediate antibody levels developed asymptomatic infections and the ex vivo parasite populations expressed only few var gene variants, indicative of clonal selection. Importantly, in contrast to parasites from naïve volunteers, expression of var genes coding for endothelial protein C receptor (EPCR)-binding PfEMP1 that are associated with severe childhood malaria was rarely detected in semi-immune adult African volunteers. Moreover, we followed var gene expression for up to six parasite replication cycles and demonstrated for the first time in vivo a shift in the dominant var gene variant. In conclusion, our data suggest that P. falciparum activates multiple subtelomeric var genes at the onset of blood stage infection facilitating rapid expansion of parasite clones which express PfEMP1 variants unrecognized by the host's immune system, thus promoting overall parasite survival in the face of host immunity.

Identifiants

pubmed: 31295334
doi: 10.1371/journal.ppat.1007906
pii: PPATHOGENS-D-19-00325
pmc: PMC6650087
doi:

Substances chimiques

Antibodies, Protozoan 0
Protozoan Proteins 0
erythrocyte membrane protein 1, Plasmodium falciparum 0

Types de publication

Controlled Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007906

Subventions

Organisme : NIAID NIH HHS
ID : R44 AI058375
Pays : United States
Organisme : NIAID NIH HHS
ID : R44 AI055229
Pays : United States

Déclaration de conflit d'intérêts

BKLS (Executive Vice President Process Development and Manufacturing) and SLH (Chief Executive and Scientific Officer) are employees of Sanaria Inc. This affiliation does not alter our adherence to all PLOS policies on sharing data and materials. All other authors declare that no competing interests exist.

Références

Int J Parasitol. 2008 Aug;38(10):1099-109
pubmed: 18395207
J Leukoc Biol. 2007 Nov;82(5):1027-32
pubmed: 17615380
J Infect Dis. 2011 Jul 1;204(1):27-35
pubmed: 21628655
Nat Med. 1998 Mar;4(3):358-60
pubmed: 9500614
Malar J. 2005 Apr 27;4:21
pubmed: 15857512
PLoS Pathog. 2011 Mar;7(3):e1001306
pubmed: 21408201
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21801-6
pubmed: 20018734
PLoS Pathog. 2016 Apr 12;12(4):e1005538
pubmed: 27070311
BMC Infect Dis. 2017 Aug 23;17(1):585
pubmed: 28835215
PLoS Comput Biol. 2010 Sep 16;6(9):
pubmed: 20862303
PLoS Pathog. 2005 Nov;1(3):e26
pubmed: 16304608
PLoS Genet. 2015 May 19;11(5):e1005234
pubmed: 25993442
Nature. 1978 Jul 13;274(5667):170-2
pubmed: 351426
J Infect Dis. 2012 May 15;205(10):1593-600
pubmed: 22448008
Mol Med. 2002 Jan;8(1):16-23
pubmed: 11984002
J Infect Dis. 2004 May 15;189(10):1942-51
pubmed: 15122533
Infect Immun. 2015 Aug;83(8):3096-103
pubmed: 26015475
PLoS One. 2014 Dec 05;9(12):e114401
pubmed: 25479608
Infect Immun. 1983 Jun;40(3):985-94
pubmed: 6189787
Mol Microbiol. 2003 Mar;47(5):1265-78
pubmed: 12603733
J Immunol. 2002 Apr 1;168(7):3444-50
pubmed: 11907103
Infect Immun. 2004 Sep;72(9):5412-8
pubmed: 15322039
Nature. 1997 Jul 17;388(6639):292-5
pubmed: 9230440
PLoS One. 2013 Jul 29;8(7):e68368
pubmed: 23922654
Nat Commun. 2017 Jul 10;8:16044
pubmed: 28691708
Cell Host Microbe. 2015 Jan 14;17(1):118-29
pubmed: 25482433
Mol Biochem Parasitol. 2006 Dec;150(2):211-8
pubmed: 16996149
Infect Immun. 2006 Aug;74(8):4875-83
pubmed: 16861676
PLoS Comput Biol. 2012;8(4):e1002451
pubmed: 22511852
J Infect Dis. 2000 Jul;182(1):252-9
pubmed: 10882604
Sci Rep. 2017 Sep 18;7(1):11810
pubmed: 28924231
Blood. 2007 Feb 1;109(3):1289-97
pubmed: 17023587
Am J Trop Med Hyg. 2007 Nov;77(5):939-42
pubmed: 17984357
J Infect Dis. 2006 Jun 1;193(11):1567-74
pubmed: 16652286
PLoS Pathog. 2012;8(4):e1002665
pubmed: 22532802
J Exp Med. 1987 May 1;165(5):1269-83
pubmed: 3553414
Mol Microbiol. 2003 Dec;50(5):1527-38
pubmed: 14651636
Infect Immun. 2006 Jul;74(7):3904-11
pubmed: 16790763
Malar J. 2008 Jun 12;7:108
pubmed: 18549480
Nature. 2002 Oct 3;419(6906):498-511
pubmed: 12368864
Infect Immun. 2017 Mar 23;85(4):
pubmed: 28138022
J Exp Med. 2004 May 3;199(9):1179-90
pubmed: 15123742
Immunology. 1972 Oct;23(4):503-21
pubmed: 4628462
Malar J. 2018 Oct 22;17(1):376
pubmed: 30348135
Lancet. 1990 Dec 15;336(8729):1457-60
pubmed: 1979090
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1791-800
pubmed: 22619319
Expert Rev Mol Med. 2009 May 26;11:e16
pubmed: 19467172
Nat Commun. 2016 Sep 26;7:12837
pubmed: 27667267
J Infect Dis. 2009 Aug 1;200(3):347-56
pubmed: 19552523
J Immunol. 2014 Apr 15;192(8):3719-29
pubmed: 24646735
Sci Rep. 2016 Jan 25;6:19882
pubmed: 26804201
PLoS Biol. 2018 Mar 12;16(3):e2004328
pubmed: 29529020
Malar J. 2015 Mar 18;14:117
pubmed: 25889522
Mol Microbiol. 2008 Jun;68(6):1519-34
pubmed: 18433451
J Infect Dis. 2016 Sep 15;214(6):884-94
pubmed: 27279526
Cell Microbiol. 2013 Dec;15(12):1976-83
pubmed: 23957661
Infect Immun. 2010 Nov;78(11):4653-9
pubmed: 20823214
Nature. 1965 Dec 25;208(5017):1286-8
pubmed: 4958335
Parasitol Today. 1999 Nov;15(11):455-7
pubmed: 10511688
BMC Med. 2017 Oct 13;15(1):183
pubmed: 29025399
Cell Host Microbe. 2017 Nov 8;22(5):601-614.e5
pubmed: 29107642
EMBO Mol Med. 2016 Aug 01;8(8):839-50
pubmed: 27354391
Eukaryot Cell. 2007 Sep;6(9):1511-20
pubmed: 17644655
Am J Trop Med Hyg. 2007 Jul;77(1):22-8
pubmed: 17620626
Mol Biochem Parasitol. 2007 Jul;154(1):98-102
pubmed: 17467073
Malar J. 2003 Sep 10;2:27
pubmed: 14565852
Malar J. 2014 Aug 25;13:333
pubmed: 25156105
J Infect Dis. 2002 Sep 1;186(5):719-22
pubmed: 12195363
Am J Trop Med Hyg. 2018 Feb;98(2):508-515
pubmed: 29260650
Clin Microbiol Infect. 2017 Mar;23(3):211.e1-211.e4
pubmed: 27773760
Bull World Health Organ. 1979;57 Suppl 1:239-43
pubmed: 317442
Nature. 2013 Jun 27;498(7455):502-5
pubmed: 23739325
J Biol Chem. 2012 Jul 6;287(28):23332-45
pubmed: 22570492
Cell Microbiol. 2011 Sep;13(9):1397-409
pubmed: 21740496

Auteurs

Anna Bachmann (A)

Department of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
German Center for Infection Research (DZIF), partner site Hamburg-Borstel-Lübeck-Riems, Germany.

Ellen Bruske (E)

Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.

Ralf Krumkamp (R)

German Center for Infection Research (DZIF), partner site Hamburg-Borstel-Lübeck-Riems, Germany.
Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Louise Turner (L)

Centre for Medical Parasitology, University of Copenhagen, Copenhagen K, Denmark.

J Stephan Wichers (JS)

Department of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Michaela Petter (M)

Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
School of BioSciences, Bio21 Institute, University of Melbourne, Parkville, Victoria, Australia.

Jana Held (J)

Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.

Michael F Duffy (MF)

School of BioSciences, Bio21 Institute, University of Melbourne, Parkville, Victoria, Australia.

B Kim Lee Sim (BKL)

Sanaria Inc., Rockville, MD, United States of America.

Stephen L Hoffman (SL)

Sanaria Inc., Rockville, MD, United States of America.

Peter G Kremsner (PG)

Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
German Center for Infection Research (DZIF), partner site Tübingen, Germany.

Bertrand Lell (B)

Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
German Center for Infection Research (DZIF), African partner institution, CERMEL, Gabon.

Thomas Lavstsen (T)

Centre for Medical Parasitology, University of Copenhagen, Copenhagen K, Denmark.

Matthias Frank (M)

Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.

Benjamin Mordmüller (B)

Institute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
German Center for Infection Research (DZIF), partner site Tübingen, Germany.

Egbert Tannich (E)

Department of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
German Center for Infection Research (DZIF), partner site Hamburg-Borstel-Lübeck-Riems, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH